@readinglight can you help us out? Live electrical line down and reported at 2am Thurs. Major crosswalk for school kids. Said you’d be back in 2 hours at 10am.
Raise the profile of your business and celebrate you and your team’s achievements by entering the 2019 #MedtechAwards! Entries close in 3 weeks time on June 7th 2019! https://t.co/qcu30jgKD1
Are you ready for our first #twitterchat? First a few house rules:
✅Start your post with Q:
✅Always use the hashtag #AskTheAnalyst
✅Tag @Pharma_Intell in your post
Follow these & we will be able to see all your questions.
We look forward to chatting with you!
There are #sponsorship opportunities still available for the 2019 #CAREAwards! Get in touch with our events team to find out more on our various packages! https://t.co/npm5j9US0e
2019 #PharmaRnDReview coming soon! Here's me giving an exclusive preview of this year's data to attendees of Japan's #AMED meeting in Tokyo on February 7th.
4 Days remain! Listen to our #podcast to find out WHY you should enter the 2019 #CAREAwards! But hurry - entries close on Friday! https://t.co/SLtfTQWjFO
Join us on November 14th at 4pm (GMT) / 11am (EDT) to find out more about how originator companies face up to the biosimilar challenge. Register here https://t.co/074jxoe3g9 #webinar
Register for the Completed Clinical Trials: Status Quo or No? Webinar, that is taking place next week on Tuesday 24th July at 4 pm (BST). An opportunity to gain insight on data surrounding completed #clinicaltrials for last year. Register Now: https://t.co/pfct2Och7t
The extended entry deadline for the @PharmaScrip 2018 is fast approaching. Make sure you submit your application by Friday15th June 2018. Enter for free at https://t.co/IcFwTk2uYz and make sure you take your place among the best. #Healthcare#CROs#ClinicalTrials#Biotechnology
The eagerly anticipated follow-up #NASsupplement to the 2018 #PharmaRnDReview from #Pharmaprojects is now available. Examine the most successful new active substances (NASs) that hit the market for the first time during 2017. Download here: https://t.co/9c19ISahp5 #ClinicalTrials
The 2018 #PharmaRnDReview from #Pharmaprojects is now published, packed with facts, statistics and analysis to give you insight into the state of pharma R&D today, with a musical twist this year. Download your free copy at https://t.co/NqaOm35iii
Join presenter Jack Allen as he uses the exclusive data from @Biomedtracker and @Datamonitor_HC to look at the upcoming projected market for #dyslipidemia: https://t.co/u5MNysP2gD
@Merck’s #Keytruda saw positive results in a late-stage clinical trial for advanced #lungcancer. @MarketWatch has the details on Keytruda’s huge potential, featuring estimated growth analysis from @Pharma_Intell: https://t.co/lIGxLuImll
Don't let the opportunity to win a CARE Award pass you by. You've got to be in it to win it! Submit your nomination by Friday, January 19th. https://t.co/4dWyIfhdk3
Join us in celebrating the launch of the Next Generation of Citeline at the 2018 @SCOPESummit in Orlando, Florida! Enjoy a relaxing afternoon of forward-thinking presentations and networking with your peers and the @Pharma_Intell team. #SCOPE2018 https://t.co/3LzXI8Za46
Are you aware of our biweekly podcast? @Datamonitor_ZM & @Datamonitor_JA discuss current events in the #healthcare space, leveraging Datamonitor Healthcare & @Biomedtracker to deliver you meaningful insights. Discover more today: https://t.co/5weiPyQcVH
#Sepsis is the single most expensive condition treated in hospitals, with annual costs in the US projected at nearly $24bn. Download our latest whitepaper for key analysis and insight: https://t.co/CLaP3sz57S
We’re excited for the 2018 @SCOPESummit and hope you are too. Be sure to visit the Pharma Intelligence Booth #617 to learn about the Next Generation of @Citeline. Discover more today. #SCOPE2018